Chinese guidelines for treatment of adult primary immune thrombocytopenia
Xin-guang Liu,Xiao-chuan Bai,Fang-ping Chen,Yun-feng Cheng,Ke-sheng Dai,Mei-yun Fang,Jian-Ming Feng,Yu-ping Gong,Tao Guo,Xin-hong Guo,Yue Han,Luo-jia Hong,Yu Hu,Bao-lai Hua,Rui-bing Huang,Yan Li,Jun Peng,Mi-mi Shu,Jing Sun,Pei-yan Sun,Yu-qian Sun,Chun-sen Wang,Shu-jie Wang,Xiao-min Wang,Cong-ming Wu,Wen-man Wu,Zhen-yu Yan,Feng-e Yang,Lin-hua Yang,Ren-Chi Yang,Tong-hua Yang,Xu Ye,Guang-sen Zhang,Lei Zhang,Chang-cheng Zheng,Hu Zhou,Min Zhou,Rong-fu Zhou,Ze-ping Zhou,Hong-li Zhu,Tie-nan Zhu,Ming Hou
DOI: https://doi.org/10.1007/s12185-018-2445-z
2018-04-04
International Journal of Hematology
Abstract:Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, definitions, outcome criteria, bleeding assessment, diagnosis, and management of ITP. The Chinese consensus reports for diagnosis and management of adult ITP have been updated to the 4th edition. Based on current consensus positions and new emerging clinical evidence, the thrombosis and hemostasis group of the Chinese Society of Hematology issued Chinese guidelines for management of adult ITP, which aim to provide evidence-based recommendations for clinical decision making.
hematology